Security tools keep companies’ technology systems safe—but only if they’re working properly. Unfortunately, they may actually give analysts a false sense of security if they’re not performing as ...

As Salil Parekh marks eight years at the helm and Infosys heads into Q3 earnings, investors will track demand signals, AI ...

Though Diablo IV recently went gold after a lengthy development, that hasn't stopped the team at Blizzard from iterating and planning for the future of their upcoming live-service action RPG -- a fact ...

Editor’s Note: The following contains spoilers for ‘The Copenhagen Test’Peacock’s The Copenhagen Test starts as a slick spy thriller, then folds into some rather dark, brutal sci-fi ideas about ...

FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (ALBT), a developer of precision diagnostic consumer products, today announced that Michael Mathews, a member of the Company’s ...

FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon” or the "Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that Michael ...

It has been a busy year for news, but now is the time to test yourself to see how much you remember, in our quiz. We're giving readers the chance to play our annual quiz of the year. From ...

Investing apps have grown in popularity in recent years and for good reason: Just about anyone can get access to the stock market with just a few taps on their phone. For beginners, investing apps ...

Market entry decisions in pharmaceuticals carry extraordinary weight. Each choice influences billions in investment, years of development effort, and ultimately patient access to innovative therapies.